January 24, 2012
Acura Pharmaceuticals Inc. on Monday agreed to pay $1.5 million to resolve a putative shareholder class action in Illinois federal court claiming the drugmaker misrepresented the chances that its flagship painkiller Acurox would gain regulatory approval in order to inflate its stock price.